Is it safe to use cefixime (a cephalosporin) together with azithromycin (a macrolide) during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, you can use cefixime with azithromycin during pregnancy

Both cefixime and azithromycin are considered safe for use during pregnancy, and this combination is specifically recommended in certain clinical scenarios, particularly for treating sexually transmitted infections.

Safety Profile of Each Drug

Cefixime in Pregnancy

  • FDA Pregnancy Category B - Animal studies show no fetal harm, though adequate human studies are limited 1
  • Should be used during pregnancy "only if clearly needed" per FDA labeling 1
  • A clinical study of 102 pregnant women treated with cefixime 400 mg single dose showed 95.2% cure rate with minimal side effects (only 3 patients reported nausea/vomiting or diarrhea) 2
  • Pharmacokinetic studies confirm extremely low penetration into fetal tissues and breast milk (<1% of dose) 3
  • No evidence of teratogenicity or adverse fetal outcomes 4

Azithromycin in Pregnancy

  • FDA Pregnancy Category B 5
  • Specifically recommended for pregnant women in multiple guidelines 6
  • The 2024 Conjunctivitis Preferred Practice Pattern explicitly states: "Pregnant women should not be treated with doxycycline, quinolones, or tetracyclines. Either erythromycin or amoxicillin is recommended for treatment of chlamydia during pregnancy" - but notably lists azithromycin as acceptable 6
  • A 2020 respiratory task force guideline classifies azithromycin as "probably safe" during pregnancy 7

Clinical Context for Combined Use

The combination of a cephalosporin (like cefixime) plus azithromycin is specifically recommended for:

  1. Gonococcal infections with presumed chlamydial co-infection - The CDC recommends treating gonorrhea patients routinely with a regimen effective against chlamydia because co-infection is common 6

  2. Cesarean delivery prophylaxis - Adding azithromycin to cephalosporin prophylaxis reduces maternal infectious morbidity and is cost-effective 8, 9

  3. Preterm pre-labor rupture of membranes (PPROM) - Cephalosporin plus macrolide combinations are effective 10

Important Caveats

Azithromycin Considerations

  • While generally safe, some studies report conflicting data on potential risks including spontaneous miscarriage, congenital malformations, and preterm birth - though no conclusive evidence supports causation 11
  • Very low risk of infantile hypertrophic pyloric stenosis when used in breastfeeding mothers during first 13 days (not after 2 weeks) 7
  • Should only be used "when clinically indicated, if benefits outweigh potential risks" 11

Cefixime Considerations

  • During pregnancy, increased volume of distribution and clearance may require dosing adjustments, though specific recommendations for pregnant women are limited 4
  • The standard 400 mg single dose has proven effective and well-tolerated 2

Practical Recommendation

Use this combination when treating:

  • Gonorrhea (cefixime 400 mg single dose) plus presumed chlamydia (azithromycin 1 g single dose) 6
  • As surgical prophylaxis for cesarean delivery in labor or after membrane rupture 8
  • For PPROM management when antibiotics are indicated 10

Both drugs have acceptable safety profiles in pregnancy (Category B), with the combination specifically endorsed in multiple clinical guidelines for pregnant women. The benefits of treating active infection or preventing surgical site infection clearly outweigh theoretical risks in these scenarios.

References

Research

[Cefixime in urinary tract infections in women].

Urologiia (Moscow, Russia : 1999), 2025

Research

Two Prophylactic Antibiotic Protocols Compared for the Treatment of Preterm Pre-labour Rupture of Membranes.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.